Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.57 by 19.3 percent. This is a 15.25 percent increase over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $3.80 billion which beat the analyst consensus estimate of $3.78 billion by 0.53 percent. This is a 2.81 percent decrease over sales of $3.91 billion the same period last year.
Nike Challenges Texas CBD Company’s Bid To Use ‘Just Hemp It’ As Brand Logo
One of the biggest multinational sportswear companies in the world, Nike (NYSE: NKE), is challenging a Texas-based CBD business trademark application.
